ANSAID TABLETS 100 MG 100 MG
FLURBIPROFEN : 100 MG · DIN 00600792 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is ANSAID TABLETS 100 MG?
ANSAID TABLETS 100 MG 100 MG contains FLURBIPROFEN : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00600792, held by PFIZER CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Jul-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ANSAID TABLETS 100 MG used for?
Relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis; relief of pain associated with dysmenorrhoea; relief of mild to moderate pain with inflammation.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00600792 |
|---|---|
| Brand name | ANSAID TABLETS 100 MG |
| Generic / active ingredient | FLURBIPROFEN : 100 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AE09 FLURBIPROFEN |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 25-Jul-2013 |
| Original market date | 1985-12-31 00:00:00 |
How is it administered?
Use lowest effective dose for shortest duration. For OA/RA: 200-300 mg/day in 2-4 divided doses. Dysmenorrhoea: 50 mg q6h. Mild-moderate pain: 50 mg q6h. Max 300 mg/day.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at 15-30°C (Standard USP range, though specific text was truncated, summary table implies standard handling).
How is it supplied?
50 mg and 100 mg tablets. (Specific container types like bottles not detailed in provided text summary).
Contraindications
CABG surgery peri-operative setting; 3rd trimester pregnancy; breastfeeding; severe heart failure; hypersensitivity to flurbiprofen/NSAIDs; ASA-intolerance; active GI ulcer/bleeding; severe liver/renal impairment.
Warnings and precautions
Risk of serious cardiovascular (MI, stroke) and gastrointestinal (ulcer, perforation, bleed) events. May cause hypertension, fluid retention, and serious skin reactions (SJS/TEN).
What can be used instead?
Other Canadian products sharing ATC code M01AE09 FLURBIPROFEN. 2 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLURBIPROFEN | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 01912038 |
| FLURBIPROFEN | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 01912046 |
| ANSAID TABLETS 50 MG | 50 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00647942 |
| FLURBIPROFEN-100 TAB 100MG | 100 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 01947737 |
| FLURBIPROFEN-50 TAB 50MG | 50 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 01947729 |
| FROBEN | 100 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223074 |
| FROBEN | 50 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223066 |
| FROBEN SR | 200 MG | CAPSULE (SUSTAINED-RELEASE) | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223082 |
| FROBEN TAB 100MG | 100 MG | TABLET | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | DIN 00593354 |
| FROBEN TAB 50MG | 50 MG | TABLET | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | DIN 00593346 |
Who else supplies FLURBIPROFEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLURBIPROFEN appears in 15 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.